Stay updated on GEMINI 1 Tolebrutinib Clinical Trial

Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:07:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-28T03:12:51.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Localization change: 'Mexico' becomes 'México' for the location entries 03100 and 06700. Version updated from v3.0.1 to v3.0.2, and the 'Back to Top' element is removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:30.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:18:43.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a list of publications related to the Tolebrutinib Phase 3 GEMINI trial. Several previous locations and related topics have been removed.
    Difference
    8%
    Check dated 2025-08-30T11:57:36.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T04:41:01.000Z thumbnail image

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.